Towards the synthesis and delivery of a halogenated MCT1 substrate
<p>The monocarboxylate transporter 1 (MCT1) has received special attention as a potential therapeutic target in cancer thanks to its role in lactate shuttling. In breast cancer (BC), high MCT1 expression has been correlated with basal-like phenotype and a ‘triple-negative’ status, an aggressiv...
Auteur principal: | Skaripa-Koukelli, Eirini |
---|---|
Autres auteurs: | Vallis, K |
Format: | Thèse |
Langue: | English |
Publié: |
2019
|
Sujets: |
Documents similaires
-
Towards Effective Targeted Alpha Therapy for Neuroendocrine Tumours: A Review
par: Paul M. D. Gape, et autres
Publié: (2024-03-01) -
Imaging and therapy with radionuclide labeled magnetic nanoparticles
par: Perihan Ünak
Publié: (2008-12-01) -
Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles
par: Iturrioz-Rodríguez N, et autres
Publié: (2019-05-01) -
RNA nanostructures for targeted drug delivery and imaging
par: Laura Teodori, et autres
Publié: (2024-12-01) -
RGD Forever!—Past, Present, and Future of a 3-Letter-Code in Radiopharmacy and Life Sciences
par: Johannes Notni
Publié: (2022-12-01)